belizatinib (TSR-011) - GSK
Q3 2012 Results (Tesaro) - Oct 26, 2012 - Anticipated initiation of P1/2 trial for NSCLC in H2 2012 
Anticipated new P1/2 trial • Non Small Cell Lung Cancer
http://www.larvolonline.com/tlg/ccdb/TesaroQ32012ResultsOct252012.pdf
 
Oct 26, 2012
 
.